COMMUNIQUÉS West-GlobeNewswire

Salarius Pharmaceuticals Announces Senior Leadership Changes
13/09/2019
Scott Jordan Appointed Chief Business Officer; Mark Rosenblum, Appointed Interim Chief Financial Officer HOUSTON, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage [...]
Akesis Galaxy™ SRS System Receives 510(k) Clearance
13/09/2019
CONCORD, Calif., Sept. 13, 2019 (GLOBE NEWSWIRE) -- The Akesis Galaxy™, a gamma stereotactic radiosurgery system (SRS) with continuous 360 o rotational technology, has received 510(k) clearance from the U.S. Food and [...]
Nexstim Plc Agrees on a New Loan Repayment Schedule with Kreos
13/09/2019
Company announcement, Helsinki, 13 September 2019 at 3.00 pm (EEST) Nexstim Plc Agrees on a New Loan Repayment Schedule with Kreos Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") – the company developing and [...]
VitalHub Announces Commencement of Second Phase of Licensing Agreement with The Salvation Army Toronto Grace Health Centre
13/09/2019
TORONTO, Sept. 13, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce that upon successful completion of the first phase of the project, it has entered phase two of the B Care EHR [...]
Todos Medical Signs Binding Term Sheet with HWH World for Network Marketing of Blood Tests for the Early Detection of Breast Cancer
13/09/2019
REHOVOT, Israel and SINGAPORE, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) , a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of [...]
Microbot Medical Announces Outcome of Annual Meeting of Shareholders
13/09/2019
Maintains Regulatory Pre-Submission Timeline of the Self-Cleaning Shunt (SCS TM ) HINGHAM, Mass., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Having successfully executed a number of significant milestones over the past twelve [...]
Adamas Pharmaceuticals Appoints Neil McFarlane as Chief Executive Officer
13/09/2019
- Gregory Went, Ph.D., Founder, transitions to a strategic advisory role - David Mahoney, lead independent director, appointed to Chairman of the Board EMERYVILLE, Calif., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Adamas [...]
Helius Medical Technologies, Inc. Announces Addition of a New PoNS™ Clinic in Quebec City, Canada
13/09/2019
NEWTOWN, Pa., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported that Clinique [...]
Applied Therapeutics to Present Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy at the Heart Failure Society of America (HFSA) 23rd Annual Scientific Meeting
13/09/2019
NEW YORK, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics Inc. (Nasdaq:APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in [...]
Vectura provides update on GSK Litigation
13/09/2019
Vectura provides update on GSK Litigation Chippenham, UK – 13 September 2019 : Vectura Group plc (LSE: VEC) ("Vectura" or "the Group") announces that following the award of US$89.7m in damages to Vectura by a jury in [...]
Orchard Therapeutics Announces Departure of Chief Commercial Officer
13/09/2019
BOSTON and LONDON, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life- [...]
Teleflex to Support Responding to Cardiac Arrest at ERC Congress 2019, in Ljubljana, Slovenia from September 19th – 21st
13/09/2019
WAYNE, Pa., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, will focus on its Arrow® EZ-IO® Intraosseous Access System and on the campaigns “What [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
13/09/2019
Company announcement – No. 34/ 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, September 13, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 [...]
Atara Biotherapeutics Reports Early Findings of Potential Efficacy from Phase 1 Study of ATA188 in Patients with Progressive Multiple Sclerosis at ECTRIMS 2019
13/09/2019
Enrollment in the fourth and final planned Phase 1 dose escalation cohort completed ATA188 targets Epstein-Barr Virus (EBV)-infected B cells, believed to play a role in the pathogenesis of multiple sclerosis Conference [...]
Catalyst Pharmaceuticals, Inc. Determines Not to Proceed with Previously Announced Public Offering of Common Stock
13/09/2019
CORAL GABLES, Fla., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (NasdaqCM: CPRX) today announced that it will not conclude the offering of shares of its common stock announced on Wednesday, [...]
Digirad Announces Listing and Trading of Preferred Stock on Nasdaq Global Market Under Symbol “DRADP”
13/09/2019
SUWANEE, Ga., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or the “Company”) announced that its newly issued 10.0% Series A Cumulative Perpetual Preferred Stock, with a stated value [...]
Change of Chairman at ALK
13/09/2019
ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that Steen Riisgaard, ALK’s Chairman of the Board, has informed the Board of Directors of his intention to step down at the company's next Annual General [...]
Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis
13/09/2019
Post-hoc analysis from a Phase III open-label extension study showed a 42 percent reduction in the risk of PPMS patients needing a wheelchair after 6.5 years of OCREVUS treatment compared with patients who started [...]
Innate Pharma reports first half 2019 financial results and business update
13/09/2019
INNATE PHARMA REPORTS FIRST HALF 2019 FINANCIAL RESULTS AND BUSINESS UPDATE Initiation of multi-cohort IPH4102 Phase II clinical trial (TELLOMAK) Sézary Syndrome cohort designed to be pivotal; preclinical data supports [...]

Pages